Risk factors for readmission in patients with ovarian, fallopian tube, and primary peritoneal carcinoma who are receiving front-line chemotherapy on a clinical trial (GOG 218): an...

por Duska, Linda R., Java, James J., Cohn, David E., Burger, Robert A.
Publicado en Gynecol Oncol (2015)

Pathologic and Treatment Outcomes Among a Geriatric Population of Endometrial Cancer Patients: An NRG Oncology/Gynecologic Oncology Group Ancillary Data Analysis of LAP2

por Bishop, Erin A., Java, James J., Moore, Kathleen N., Walker, Joan L.
Publicado en Int J Gynecol Cancer (2017)

Mixed-methods content and sentiment analysis of adolescents’ voice-diaries describing daily experiences with asthma and self-management decision-making

por Mammen, Jennifer R., Java, James J., Rhee, Hyekyun, Butz, Arlene M., Halterman, Jill S., Arcoleo, Kimberly
Publicado en Clin Exp Allergy (2018)

Nodal Metastasis Risk in Endometrioid Endometrial Cancer

por Milam, Michael R., Java, James, Walker, Joan L., Metzinger, Daniel S., Parker, Lynn P., Coleman, Robert L.
Publicado 2012

Locally advanced adenocarcinoma and adenosquamous carcinomas of the cervix compared to squamous cell carcinomas of the cervix in Gynecologic Oncology Group trials of cisplatin-base...

por Rose, Peter G, Java, James J, Whitney, Charles W., Stehman, Frederick B, Lanciano, Rachelle, Thomas, Gillian M
Publicado en Gynecol Oncol (2014)

Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: A Gynecologic Oncology Group study()

por Landrum, Lisa M., Java, James, Mathews, Cara A., Lanneau, Grainger S., Copeland, Larry J., Armstrong, Deborah K., Walker, Joan L.
Publicado en Gynecol Oncol (2013)

Survival in Women With Grade 1 Serous Ovarian Carcinoma

por Fader, Amanda Nickles, Java, James, Ueda, Stefanie, Bristow, Robert E., Armstrong, Deborah K., Bookman, Michael A., Gershenson, David M.
Publicado en Obstet Gynecol (2013)

The association between timing of initiation of adjuvant therapy and the survival of early stage ovarian cancer patients – An analysis of NRG Oncology/Gynecologic Oncology Group tr...

por Chan, John K., Java, James J., Fuh, Katherine, Monk, Bradley J., Kapp, Daniel S., Herzog, Thomas, Bell, Jeffrey, Young, Robert
Publicado en Gynecol Oncol (2016)

Long-Term Survival Advantage and Prognostic Factors Associated With Intraperitoneal Chemotherapy Treatment in Advanced Ovarian Cancer: A Gynecologic Oncology Group Study

por Tewari, Devansu, Java, James J., Salani, Ritu, Armstrong, Deborah K., Markman, Maurie, Herzog, Thomas, Monk, Bradley J., Chan, John K.
Publicado en J Clin Oncol (2015)

Nomograms Predicting Progression-Free Survival, Overall Survival, and Pelvic Recurrence in Locally Advanced Cervical Cancer Developed From an Analysis of Identifiable Prognostic Fa...

por Rose, Peter G., Java, James, Whitney, Charles W., Stehman, Frederick B., Lanciano, Rachelle, Thomas, Gillian M., DiSilvestro, Paul A.
Publicado en J Clin Oncol (2015)

The prognostic significance of pre- and post-treatment CA-125 in grade 1 serous ovarian carcinoma: A Gynecologic Oncology Group study(, )

por Fader, Amanda Nickles, Java, James, Krivak, Thomas C., Bristow, Robert E., Tergas, Ana I., Bookman, Michael A., Armstrong, Deborah K., Tanner, Edward J., Gershenson, David M.
Publicado en Gynecol Oncol (2013)

Measuring the Severity of Respiratory Illness in the First 2 Years of Life in Preterm and Term Infants

por Caserta, Mary T., Yang, Hongmei, Bandyopadhyay, Sanjukta, Qiu, Xing, Gill, Steven R., Java, James, McDavid, Andrew, Falsey, Ann R., Topham, David J., Holden-Wiltse, Jeanne, Scheible, Kristin, Pryhuber, Gloria
Publicado en J Pediatr (2019)

A mixed‐methods analysis of younger adults' perceptions of asthma, self‐management, and preventive care: "This isn't helping me none"

por Mammen, Jennifer R., Turgeon, Kelsey, Philibert, Ashley, Schoonmaker, Judith D., Java, James, Halterman, Jill, Berliant, Marc N., Crowley, Amber, Reznik, Marina, Feldman, Jonathan M., Fortuna, Robert J., Arcoleo, Kimberly
Publicado en Clin Exp Allergy (2020)

Disease Extent at Secondary Cytoreductive Surgery is Predictive of Progression-free and Overall Survival in Advanced Stage Ovarian Cancer: an NRG Oncology/Gynecologic Oncology Grou...

por Rose, Peter G., Java, James J., Morgan, Mark A., Secord, Angeles Alvarez, Kesterson, Joshua P., Stehman, Frederick B., Warshal, David P., Creasman, William T., Hanjani, Parviz, Morris, Robert T., Copeland, Larry J.
Publicado en Gynecol Oncol (2016)

Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: An NRG Oncology/GOG study

por Ferriss, James S, Java, James J, Bookman, Michael A, Fleming, Gini F, Monk, Bradley J, Walker, Joan L, Homesley, Howard D, Fowler, Jeffrey, Greer, Benjamin E, Boente, Matthew P, Burger, Robert A
Publicado en Gynecol Oncol (2015)

Impact of tumour histology on survival in advanced cervical carcinoma: an NRG Oncology/Gynaecologic Oncology Group Study

por Seamon, Leigh G, Java, James J, Monk, Bradley J, Penson, Richard T, Brown, Jubilee, Mannel, Robert S, Oaknin, Anna, Leitao, Mario M, Eisenhauer, Eric L, Long, Harry J, Liao, Shu Y, Tewari, Krishnansu S
Publicado en Br J Cancer (2018)

Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group...

por Garcia-Soto, Arlene E, Java, James J, Neira, Wilberto Nieves, Pearson, J Matthew, Cohn, David E., Lele, Shashikant B, Tewari, Krishnansu S, Walker, Joan L, Secord, Angeles Alvarez, Armstrong, Deborah K, Copeland, Larry J
Publicado en Gynecol Oncol (2016)

Temporal Dysbiosis of Infant Nasal Microbiota Relative to Respiratory Syncytial Virus Infection

por Grier, Alex, Gill, Ann L, Kessler, Haeja A, Corbett, Anthony, Bandyopadhyay, Sanjukta, Java, James, Holden-Wiltse, Jeanne, Falsey, Ann R, Topham, David J, Mariani, Thomas J, Caserta, Mary T, Walsh, Edward E, Gill, Steven R
Publicado en J Infect Dis (2020)

Does Adjuvant Chemotherapy Dose Modification Have an Impact On the Outcome of Patients diagnosed with Advanced Stage Ovarian Cancer? An NRG Oncology/Gynecologic Oncology Group Stud...

por Olawaiye, Alexander B., Java, James J., Krivak, Thomas C., Friedlander, Michael, Mutch, David G., Glaser, Gretchen, Geller, Melissa, O’Malley, David M., Wenham, Robert M., Lee, Roger B., Bodurka, Diane C., Herzog, Thomas J., Bookman, Michael A.
Publicado en Gynecol Oncol (2018)

Corrigendum to “Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Onc...

por Olawaiye, Alexander B., Java, James J., Krivak, Thomas C., Friedlander, Michael, Mutch, David G., Glaser, Gretchen, Geller, Melissa, O'Malley, David M., Wenham, Robert M., Lee, Roger B., Bodurka, Diane C., Herzog, Thomas J., Bookman, Michael A.
Publicado en Gynecol Oncol (2018)